Sibiromycin is an aminoglycoside antibiotic produced by Streptosporangium sibiricum that also exhibits antitumour properties. It functions as an antineoplastic agent and a bacterial metabolite, belonging to the pyrrolobenzodiazepine class.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Sibiromycin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
JQ1 compound
pharmaceutical raw material
Encorafenib
pharmaceutical raw material
Pyrotinib
pharmaceutical raw material
Hydroxycarbamide
pharmaceutical raw material
(6R,6aS)-2-[(2S,3R,4R,5S,6S)-3,4-dihydroxy-4,6-dimethyl-5-(methylamino)oxan-2-yl]oxy-4,6-dihydroxy-3-methyl-8-[(E)-prop-1-enyl]-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-11-one
RAGFPHFDFVNLCG-INYQBOQCSA-N
C/C=C/C1=CN2[C@@H](C1)[C@H](NC3=C(C(=C(C=C3C2=O)O[C@H]4[C@@H]([C@]([C@H]([C@@H](O4)C)NC)(C)O)O)C)O)O
Sourcing Sibiromycin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.